116551004: Phenyltoloxamine citrate (substance)

SNOMED CT Concept\substance\...

\Substance categorized by disposition\Substance with receptor antagonist mechanism of action (substance)\antihistaminique\Ethanolamine derivative antihistamine\Phenyltoloxamine citrate

\substance catégorisée selon sa structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amine and/or amine derivative\Ethanolamine and/or ethanolamine derivative (substance)\Ethanolamine derivative antihistamine\Phenyltoloxamine citrate

\Organic compound\Organic nitrogen compound\Amine and/or amine derivative\Ethanolamine and/or ethanolamine derivative (substance)\Ethanolamine derivative antihistamine\Phenyltoloxamine citrate

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Phenyltoloxamine citrate	est un(e) (attribut)	Ethanolamine derivative histamine receptor antagonist product	false	Inferred relationship	Some
Phenyltoloxamine citrate	est un(e) (attribut)	Sedating antihistamine (substance)	false	Inferred relationship	Some
Phenyltoloxamine citrate	est un(e) (attribut)	Phenyltoloxamine (substance)	false	Inferred relationship	Some
Phenyltoloxamine citrate	Has disposition (attribute)	Histamine receptor antagonist (disposition)	true	Inferred relationship	Some
Phenyltoloxamine citrate	Is modification of (attribute)	Phenyltoloxamine (substance)	true	Inferred relationship	Some
Phenyltoloxamine citrate	est un(e) (attribut)	Ethanolamine derivative antihistamine	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug)	Has basis of strength substance (attribute)	True	Phenyltoloxamine citrate	Inferred relationship	Some	1
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug)	Has precise active ingredient	True	Phenyltoloxamine citrate	Inferred relationship	Some	1
Acetaminophen 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet	Has basis of strength substance (attribute)	True	Phenyltoloxamine citrate	Inferred relationship	Some	1
Acetaminophen 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet	Has precise active ingredient	True	Phenyltoloxamine citrate	Inferred relationship	Some	1
Acetaminophen 500 mg and phenyltoloxamine citrate 60 mg oral tablet	Has basis of strength substance (attribute)	True	Phenyltoloxamine citrate	Inferred relationship	Some	1
Acetaminophen 500 mg and phenyltoloxamine citrate 60 mg oral tablet	Has precise active ingredient	True	Phenyltoloxamine citrate	Inferred relationship	Some	1
Acetaminophen 650 mg and phenyltoloxamine citrate 50 mg oral tablet	Has precise active ingredient	True	Phenyltoloxamine citrate	Inferred relationship	Some	1
Acetaminophen 500 mg and phenyltoloxamine citrate 30 mg oral tablet	Has precise active ingredient	True	Phenyltoloxamine citrate	Inferred relationship	Some	1
Acetaminophen 500 mg and phenyltoloxamine citrate 30 mg oral tablet	Has basis of strength substance (attribute)	True	Phenyltoloxamine citrate	Inferred relationship	Some	1
Chlorpheniramine maleate+phenylephrine hydrochloride+phenyltoloxamine citrate 4mg/20mg/50mg m/r capsule (product)	a pour principe actif (attribut)	False	Phenyltoloxamine citrate	Inferred relationship	Some
Chlorpheniramine maleate+phenylephrine hydrochloride+phenyltoloxamine citrate 2.5mg/5mL 5mg/5mL 7.5mg/5mL liquid (product)	a pour principe actif (attribut)	False	Phenyltoloxamine citrate	Inferred relationship	Some
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug)	a pour principe actif (attribut)	False	Phenyltoloxamine citrate	Inferred relationship	Some
Acetaminophen 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet	a pour principe actif (attribut)	False	Phenyltoloxamine citrate	Inferred relationship	Some
Acetaminophen + phenyltoloxamine citrate 500mg/30mg caplets (product)	a pour principe actif (attribut)	False	Phenyltoloxamine citrate	Inferred relationship	Some
Acetaminophen 500 mg and phenyltoloxamine citrate 50 mg oral tablet	a pour principe actif (attribut)	False	Phenyltoloxamine citrate	Inferred relationship	Some
Acetaminophen 500 mg and phenyltoloxamine citrate 60 mg oral tablet	a pour principe actif (attribut)	False	Phenyltoloxamine citrate	Inferred relationship	Some
Acetaminophen 650 mg and phenyltoloxamine citrate 50 mg oral tablet	a pour principe actif (attribut)	False	Phenyltoloxamine citrate	Inferred relationship	Some
Acetaminophen + phenyltoloxamine citrate	a pour principe actif (attribut)	False	Phenyltoloxamine citrate	Inferred relationship	Some
Chlorpheniramine maleate+phenylephrine hydrochloride+phenyltoloxamine citrate (product)	a pour principe actif (attribut)	False	Phenyltoloxamine citrate	Inferred relationship	Some
Acetaminophen + phenyltoloxamine citrate + salicylamide	a pour principe actif (attribut)	False	Phenyltoloxamine citrate	Inferred relationship	Some
Acetaminophen 500 mg and phenyltoloxamine citrate 50 mg oral tablet	a pour principe actif (attribut)	False	Phenyltoloxamine citrate	Inferred relationship	Some	1
Acetaminophen 500 mg and phenyltoloxamine citrate 50 mg oral tablet	Has basis of strength substance (attribute)	True	Phenyltoloxamine citrate	Inferred relationship	Some	1
Acetaminophen 500 mg and phenyltoloxamine citrate 60 mg oral tablet	a pour principe actif (attribut)	False	Phenyltoloxamine citrate	Inferred relationship	Some	2
Acetaminophen 500 mg and phenyltoloxamine citrate 60 mg oral tablet	Has basis of strength substance (attribute)	False	Phenyltoloxamine citrate	Inferred relationship	Some	2
Acetaminophen 650 mg and phenyltoloxamine citrate 50 mg oral tablet	Has basis of strength substance (attribute)	False	Phenyltoloxamine citrate	Inferred relationship	Some	2
Acetaminophen 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet	a pour principe actif (attribut)	False	Phenyltoloxamine citrate	Inferred relationship	Some	3
Acetaminophen 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet	Has basis of strength substance (attribute)	False	Phenyltoloxamine citrate	Inferred relationship	Some	3
Acetaminophen 650 mg and phenyltoloxamine citrate 50 mg oral tablet	a pour principe actif (attribut)	False	Phenyltoloxamine citrate	Inferred relationship	Some	1
Acetaminophen 650 mg and phenyltoloxamine citrate 50 mg oral tablet	Has basis of strength substance (attribute)	True	Phenyltoloxamine citrate	Inferred relationship	Some	1
Acetaminophen 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet	Has basis of strength substance (attribute)	False	Phenyltoloxamine citrate	Inferred relationship	Some	2
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug)	a pour principe actif (attribut)	False	Phenyltoloxamine citrate	Inferred relationship	Some	2
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug)	Has basis of strength substance (attribute)	False	Phenyltoloxamine citrate	Inferred relationship	Some	2
Acetaminophen 500 mg and phenyltoloxamine citrate 30 mg oral tablet	Has basis of strength substance (attribute)	False	Phenyltoloxamine citrate	Inferred relationship	Some	2
Acetaminophen 500 mg and phenyltoloxamine citrate 50 mg oral tablet	Has precise active ingredient	True	Phenyltoloxamine citrate	Inferred relationship	Some	1
Acetaminophen 650 mg and phenyltoloxamine citrate 50 mg oral tablet	Has precise active ingredient	False	Phenyltoloxamine citrate	Inferred relationship	Some	2
Acetaminophen 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet	Has precise active ingredient	False	Phenyltoloxamine citrate	Inferred relationship	Some	2
Acetaminophen 500 mg and phenyltoloxamine citrate 60 mg oral tablet	Has precise active ingredient	False	Phenyltoloxamine citrate	Inferred relationship	Some	2
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug)	Has precise active ingredient	False	Phenyltoloxamine citrate	Inferred relationship	Some	2
Acetaminophen 500 mg and phenyltoloxamine citrate 30 mg oral tablet	Has precise active ingredient	False	Phenyltoloxamine citrate	Inferred relationship	Some	2

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
203177017	Phenyltoloxamine citrate	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
23311000188113	phényltoloxamine citrate	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Common French translation module (core metadata concept)
514551000241118	citrate de phényltoloxamine (substance)	fr	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Common French translation module (core metadata concept)
679589015	Phenyltoloxamine citrate (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
833271000172110	citrate de phényltoloxamine	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Common French translation module (core metadata concept)